What it is: A naturally produced pregnancy hormone that structurally mimics LH and directly stimulates testosterone production in the testes, with multiple FDA-approved indications.
Research suggests: Multiple controlled trials and decades of FDA-approved clinical use establish its role in testosterone support, fertility treatment, and testicular function maintenance.
Best for: TRT support and male fertility researchers
Key thing to know: FDA approved for hypogonadism and fertility; commonly studied alongside testosterone therapy to maintain testicular size and endogenous production.
What is HCG?
HCG (Human Chorionic Gonadotropin) is a glycoprotein hormone naturally produced during pregnancy by the placenta. It shares structural similarity with LH (Luteinizing Hormone) and binds to LH receptors throughout the body. In men, LH receptor activation in Leydig cells of the testes stimulates testosterone production.
HCG effectively mimics LH, making it a well-characterized tool for stimulating endogenous testosterone production. It has multiple FDA-approved indications including treatment of hypogonadism in men and ovulation induction in women, giving it one of the strongest regulatory track records among hormonal compounds studied in this context.
Research applications include maintaining testicular function and endogenous testosterone production during exogenous testosterone use, treatment of hypogonadotropic hypogonadism, fertility support in both men and women, and hormonal axis recovery after hormonal interventions.
How it works.
HCG binds to LH receptors on testicular Leydig cells, triggering the same testosterone production response as natural LH. When exogenous testosterone is administered, the hypothalamus detects adequate testosterone levels and reduces GnRH pulsatility. This reduces LH production, which in turn reduces the signal to the testes to produce testosterone.
Over time, this leads to testicular atrophy and suppression of endogenous testosterone production.
HCG bypasses this suppression by directly stimulating LH receptors on the testes regardless of the hypothalamic-pituitary signal. The testes respond to HCG as if LH is present even when the brain has stopped sending its usual message.
Think of it as a direct signal to the testes telling them to keep working even when the normal communication chain from the brain has gone quiet. This is why it is studied for testicular maintenance during testosterone replacement therapy and for restoring function after hormonal suppression.
What the research shows.
HCG has an extensive and well-established clinical research base. Its mechanism of action through LH receptor stimulation is thoroughly characterized in the pharmacological literature. Human clinical studies document its effectiveness for hypogonadotropic hypogonadism, cryptorchidism, and fertility support across multiple decades of published research.
Use alongside testosterone replacement therapy to maintain testicular function and endogenous testosterone production is well documented in the clinical literature. Multiple randomized controlled trials and large observational studies across reproductive medicine establish a robust evidence foundation for its primary indications.
FDA approval exists for multiple indications in both men and women, giving HCG a regulatory status and human safety profile that most research peptides do not share.
Biomarkers to review first.
Research protocols for HCG typically reference the following biomarkers as baseline context. Testing these before exploring this compound gives you and your healthcare provider the most relevant starting information.
What it's commonly researched with.
In research literature, HCG frequently appears alongside other hormonal axis compounds. The combinations below represent what researchers and clinicians have studied, not recommendations for use.